Aleksandar Z Obradovic

6PUBLICATIONS
84CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2024
Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer.

Casey R Ager, Aleksandar Obradovic, Patrick McCann

|Sep 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer.

Matthew C Dallos, Aleksandar Z Obradovic, Patrick McCann

|Dec 13, 2023
Plasticity of intragraft alloreactive T cell clones in human gut correlates with transplant outcomes.

Jianing Fu, Zicheng Wang, Mercedes Martinez

|Jul 01, 2021
TGM4: an immunogenic prostate-restricted antigen.

Zoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl

Pageof 1